Relx Stock Price, News & Analysis (OTCMKTS:RLXXF) $39.86 +2.06 (+5.44%) (As of 04:20 PM ET) Add Compare Share Share Today's Range$39.86▼$39.8650-Day Range$33.10▼$39.0952-Week Range$27.00▼$39.86Volume1,766 shsAverage Volume3,004 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest About Relx Stock (OTCMKTS:RLXXF)RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.Read More RLXXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RLXXF Stock News HeadlinesOctober 11, 2023 | markets.businessinsider.comPositive Report for RELX plc (RLXXF) from CitiSeptember 21, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Technology Stocks: Intel (INTC) and RELX plc (OtherRLXXF)November 29, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comMay 10, 2021 | financialpost.comFTSE 100 edges lower as stronger pound offsets gains in minersApril 1, 2021 | financialpost.comLondon stocks rise on optimism over swift economic recoverySee More Headlines Receive RLXXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Relx and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Specialty Business Services Sub-IndustryN/A SectorIndustrials Current SymbolOTCMKTS:RLXXF CUSIPN/A CIK929869 Webwww.relx.com Phone442071665500FaxN/AEmployees35,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Erik Engstrom M.Sc Econ (Age 60)M.Sc Eng., MBA, CEO & Executive Director Comp: $4.55MMr. Nicholas Lawrence Luff (Age 56)CFO & Executive Director Comp: $2.69MMs. Kumsal Bayazit Besson (Age 49)Chief Executive Officer of Scientific, Technical & Medical Mr. Colin TennantHead of Investor RelationsMr. Henry Adam Udow (Age 65)Chief Legal Officer & Company Secretary Mr. Paul AbrahamsHead of Corporate CommunicationsMs. Rosemary Thomson (Age 54)Chief Human Resources Officer Mr. Mark KelseyChief Executive Officer of RiskMs. Jelena SevoChief Strategy OfficerMr. Michael WalshChief Executive Officer of LegalMore ExecutivesKey CompetitorsADM EndeavorsOTCMKTS:ADMQAimiaOTCMKTS:GAPFFApplus ServicesOTCMKTS:APLUFBramblesOTCMKTS:BMBLFCalian GroupOTCMKTS:CLNFFView All Competitors RLXXF Stock Analysis - Frequently Asked Questions How have RLXXF shares performed in 2023? Relx's stock was trading at $27.85 on January 1st, 2023. Since then, RLXXF shares have increased by 35.7% and is now trading at $37.80. View the best growth stocks for 2023 here. Are investors shorting Relx? Relx saw a decline in short interest in October. As of October 31st, there was short interest totaling 260,800 shares, a decline of 28.3% from the October 15th total of 363,600 shares. Based on an average trading volume of 7,000 shares, the short-interest ratio is presently 37.3 days. View Relx's Short Interest. How do I buy shares of Relx? Shares of RLXXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:RLXXF) was last updated on 11/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relx Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.